Naito Y - Search Results

1

Gut microbiota in the pathogenesis of inflammatory bowel disease.

Nishida A, Inoue R, Inatomi O, Bamba S, Naito Y, Andoh A. Nishida A, et al. Among authors: naito y. Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29. Clin J Gastroenterol. 2018. PMID: 29285689 Review.

2

Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease.

Naito Y, Takagi T, Yoshikawa T. Naito Y, et al. Aliment Pharmacol Ther. 2004 Jul;20 Suppl 1:177-84. doi: 10.1111/j.1365-2036.2004.01992.x. Aliment Pharmacol Ther. 2004. PMID: 15298625 Free article.

3

Oxidative stress-related molecules as a therapeutic target for inflammatory and allergic diseases.

Naito Y, Takano H, Yoshikawa T. Naito Y, et al. Curr Drug Targets Inflamm Allergy. 2005 Aug;4(4):511-5. doi: 10.2174/1568010054526269. Curr Drug Targets Inflamm Allergy. 2005. PMID: 16101531 Review.

4

Role of matrix metalloproteinases in inflammatory bowel disease.

Naito Y, Yoshikawa T. Naito Y, et al. Mol Aspects Med. 2005 Aug-Oct;26(4-5):379-90. doi: 10.1016/j.mam.2005.07.009. Mol Aspects Med. 2005. PMID: 16112187 Review.

5

Molecular fingerprints of neutrophil-dependent oxidative stress in inflammatory bowel disease.

Naito Y, Takagi T, Yoshikawa T. Naito Y, et al. J Gastroenterol. 2007 Oct;42(10):787-98. doi: 10.1007/s00535-007-2096-y. Epub 2007 Oct 15. J Gastroenterol. 2007. PMID: 17940831 Review.

6

The role of heme oxygenase and carbon monoxide in inflammatory bowel disease.

Takagi T, Naito Y, Uchiyama K, Yoshikawa T. Takagi T, et al. Among authors: naito y. Redox Rep. 2010;15(5):193-201. doi: 10.1179/174329210X12650506623889. Redox Rep. 2010. PMID: 21062534 Free PMC article. Review.

7

Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis.

Imaeda H, Andoh A, Aomatsu T, Uchiyama K, Bamba S, Tsujikawa T, Naito Y, Fujiyama Y. Imaeda H, et al. Among authors: naito y. Int J Mol Med. 2011 Oct;28(4):573-8. doi: 10.3892/ijmm.2011.718. Epub 2011 Jun 8. Int J Mol Med. 2011. PMID: 21667014

8

Rebamipide ameliorates indomethacin-induced small intestinal injury in rats via the inhibition of matrix metalloproteinases activity.

Yamada S, Naito Y, Takagi T, Mizushima K, Horie R, Fukumoto K, Inoue K, Harusato A, Uchiyama K, Handa O, Yagi N, Ichikawa H, Yoshikawa T. Yamada S, et al. Among authors: naito y. J Gastroenterol Hepatol. 2012 Dec;27(12):1816-24. doi: 10.1111/j.1440-1746.2012.07275.x. J Gastroenterol Hepatol. 2012. PMID: 23020299

9

[Roles of inflammatory mediators and cytokines in the pathogenesis of inflammatory bowel disease].

Naito Y, Uchiyama K, Takagi T. Naito Y, et al. Nihon Rinsho. 2012 Feb;70 Suppl 1:96-100. Nihon Rinsho. 2012. PMID: 23126074 Japanese. No abstract available.

10

Oligosaccharides from agar inhibit murine intestinal inflammation through the induction of heme oxygenase-1 expression.

Higashimura Y, Naito Y, Takagi T, Mizushima K, Hirai Y, Harusato A, Ohnogi H, Yamaji R, Inui H, Nakano Y, Yoshikawa T. Higashimura Y, et al. Among authors: naito y. J Gastroenterol. 2013 Aug;48(8):897-909. doi: 10.1007/s00535-012-0719-4. Epub 2012 Nov 28. J Gastroenterol. 2013. PMID: 23188093

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,850 results

Search Page

Filters